Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMILE-CIPN: Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy
jRCT1071250142Recruiting
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of pregabalin and mirogabalin in chemotherapy-induced peripheral neuropathy (CIPN) and breast cancer (2 arms). Primary endpoint: NRS (Numerical Rating Scale) for neuropathic pain. Started Mar 2026; status: recruiting.
02
Drugs
pregabalinmirogabalin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)breast cancer
Beyond the preview
Go deeper on jRCT1071250142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071250142.